{"id":"NCT02634580","sponsor":"Amgen","briefTitle":"Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4","officialTitle":"A Double-blind, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Evolocumab, Compared With Ezetimibe, in Hypercholesterolemic Japanese Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Reductase Inhibitor Due to Muscle Related Side Effects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02-27","primaryCompletion":"2017-08-10","completion":"2018-05-26","firstPosted":"2015-12-18","resultsPosted":"2018-08-31","lastUpdate":"2020-11-10"},"enrollment":61,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"BIOLOGICAL","name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"type":"DRUG","name":"Ezetimibe","otherNames":["Zetia"]},{"type":"DRUG","name":"Placebo to Evolocumab","otherNames":[]},{"type":"DRUG","name":"Placebo Ezetimibe","otherNames":[]}],"arms":[{"label":"Ezetimibe (Q2W)","type":"ACTIVE_COMPARATOR"},{"label":"Ezetimibe (QM)","type":"ACTIVE_COMPARATOR"},{"label":"Evolocumab Q2W","type":"EXPERIMENTAL"},{"label":"Evolocumab QM","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study was to evaluate the effect of 12 weeks of subcutaneous (SC) evolocumab compared with ezetimibe, on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in hypercholesterolemic adults unable to tolerate an effective dose of a statin.","primaryOutcome":{"measure":"Percent Change From Baseline in Low-Density Lipoprotein Cholesterol (LDL-C) at the Mean of Weeks 10 and 12","timeFrame":"Baseline and Weeks 10 and 12","effectByArm":[{"arm":"Ezetimibe","deltaMin":-20.39,"sd":3.19},{"arm":"Evolocumab","deltaMin":-59.75,"sd":2.3}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":6},"locations":{"siteCount":35,"countries":["Japan"]},"refs":{"pmids":["31748467"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":10},"commonTop":["Nasopharyngitis","Diarrhoea","Pharyngitis","Cough","Hypertension"]}}